Posterior uveal biopsy and the trans-scleral Essen forceps biopsy technique.


Journal

Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986

Informations de publication

Date de publication:
14 Oct 2024
Historique:
received: 11 03 2024
accepted: 08 10 2024
revised: 23 09 2024
medline: 15 10 2024
pubmed: 15 10 2024
entrez: 14 10 2024
Statut: aheadofprint

Résumé

Differentiating neoplastic and non-neoplastic uveal tumours can present a diagnostic challenge; intra-ocular biopsy may be necessary. The novel trans-scleral Essen Forceps biopsy (TSEB) technique can improve diagnostic yield compared to fine needle aspiration biopsy (FNAB). We present a case demonstrating the technique and its added value. We also review the success rate of TSEB performed at two tertiary eye centres. Retrospective case report and consecutive case series from August 2021 to March 2023. Inclusion criteria were patients who underwent TSEB of posterior uveal lesions from Moorfields Eye Hospital and Sheffield Teaching Hospitals in the United Kingdom. The outcomes were biopsy success rate and complication rate RESULTS: Eleven biopsies met the inclusion criteria. Eight (73%) were successful, which comprised six uveal melanomas, one melanocytoma and one extranodal marginal zone (ENMZ) lymphoma. One TSEB did not yield tissue for histological examination because of perioperative sample handling. Two (18%) biopsies were histologically inconclusive; both were treated as uveal melanoma on clinical grounds or repeat biopsy. The only complication was vitreous loss and retinal hole without retinal detachment in one eye with a very posterior, shallow choroidal lesion. TSEB is an effective alternative to established biopsy techniques, yielding larger tissue samples than FNAB with intact tissue architecture. We recommend adding TSEB to the armamentarium of the ocular oncologist.

Sections du résumé

BACKGROUND BACKGROUND
Differentiating neoplastic and non-neoplastic uveal tumours can present a diagnostic challenge; intra-ocular biopsy may be necessary. The novel trans-scleral Essen Forceps biopsy (TSEB) technique can improve diagnostic yield compared to fine needle aspiration biopsy (FNAB). We present a case demonstrating the technique and its added value. We also review the success rate of TSEB performed at two tertiary eye centres.
METHODS METHODS
Retrospective case report and consecutive case series from August 2021 to March 2023. Inclusion criteria were patients who underwent TSEB of posterior uveal lesions from Moorfields Eye Hospital and Sheffield Teaching Hospitals in the United Kingdom. The outcomes were biopsy success rate and complication rate RESULTS: Eleven biopsies met the inclusion criteria. Eight (73%) were successful, which comprised six uveal melanomas, one melanocytoma and one extranodal marginal zone (ENMZ) lymphoma. One TSEB did not yield tissue for histological examination because of perioperative sample handling. Two (18%) biopsies were histologically inconclusive; both were treated as uveal melanoma on clinical grounds or repeat biopsy. The only complication was vitreous loss and retinal hole without retinal detachment in one eye with a very posterior, shallow choroidal lesion.
CONCLUSION CONCLUSIONS
TSEB is an effective alternative to established biopsy techniques, yielding larger tissue samples than FNAB with intact tissue architecture. We recommend adding TSEB to the armamentarium of the ocular oncologist.

Identifiants

pubmed: 39402168
doi: 10.1038/s41433-024-03394-6
pii: 10.1038/s41433-024-03394-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

Nathan P, Coupland S, Lewis R, Modi S, Rashid S, Sacco J, et al. Uveal Melanoma: Full guideline, updated 2022. Melanoma Focus. 2022. https://melanomafocus.org/wp-content/uploads/2023/01/2_UM_Guideline_v7_6.pdf
Khadka S, Byanju R, Pradhan S. Posterior Scleritis Simulating Choroidal Melanoma: A Case Report. Beyoglu Eye J 2021;6:133–9.
pubmed: 35005506 pmcid: 8651019
Finger PT, Perry HD, Packer S, Erdey RA, Weisman GD, Sibony PA. Posterior scleritis as an intraocular tumour. Br J Ophthalmol. 1990;74:121–2.
doi: 10.1136/bjo.74.2.121 pubmed: 2178679 pmcid: 1042007
Liu AT, Luk FO, Chan CK. A case of giant nodular posterior scleritis mimicking choroidal malignancy. Indian J Ophthalmol. 2015;63:919–21.
doi: 10.4103/0301-4738.176038 pubmed: 26862098 pmcid: 4784081
Hage R, Jean-Charles A, Guyomarch J, Rahimian O, Donnio A, Merle H. Nodular posterior scleritis mimicking choroidal metastasis: a report of two cases. Clin Ophthalmol Auckl NZ. 2011;5:877–80.
doi: 10.2147/OPTH.S21255
Bechrakis NE, Foerster MH, Bornfeld N. Biopsy in indeterminate intraocular tumors. Ophthalmology. 2002;109:235–42.
doi: 10.1016/S0161-6420(01)00931-9 pubmed: 11825801
Heimann H, Bornfeld N, Vij O, Coupland SE, Bechrakis NE, Kellner U, et al. Vasoproliferative tumours of the retina. Br J Ophthalmol. 2000;84:1162–9.
doi: 10.1136/bjo.84.10.1162 pubmed: 11004104 pmcid: 1723269
Tsai T. O’Brien JM. Masquerade Syndromes: Malignancies Mimicking Inflammation in the Eye. Int Ophthalmol Clin. 2002;42:115–31.
doi: 10.1097/00004397-200201000-00016 pubmed: 12189607
Feng L, Zhu J, Gao T, Li B, Yang Y. Uveal Melanoma in the Peripheral Choroid Masquerading as Chronic Uveitis. Optom Vis Sci. 2014;91:e222–5.
doi: 10.1097/OPX.0000000000000350 pubmed: 25036546 pmcid: 4186724
Hussain RN, Damato B, Heimann H. Choroidal biopsies; a review and optimised approach. Eye. 2023;37:900–6.
doi: 10.1038/s41433-022-02194-0 pubmed: 35941182
Traine PG, Schedler KJE, Brusa MGS, Rodrigues EB. Biopsy with the New Essen Biopsy Forceps. Case Rep. Ophthalmol Med. 2013;2013:413259.
pubmed: 23936702 pmcid: 3722984
Frizziero L, Midena E, Trainiti S, Londei D, Bonaldi L, Bini S, et al. Uveal Melanoma Biopsy: A Review. Cancers. 2019;11:1075.
doi: 10.3390/cancers11081075 pubmed: 31366043 pmcid: 6721328
Cohen VML, Dinakaran S, Parsons MA, Rennie IG. Transvitreal fine needle aspiration biopsy: The influence of intraocular lesion size on diagnostic biopsy result. Eye. 2001;15:143–7.
doi: 10.1038/eye.2001.48 pubmed: 11339578
Akgul H, Otterbach F, Bornfeld N, Jurklies B. Intraocular biopsy using special forceps: a new instrument and refined surgical technique. Br J Ophthalmol. 2011;95:79–82.
doi: 10.1136/bjo.2008.148395 pubmed: 21163820
Angi M, Kalirai H, Taktak A, Hussain R, Groenewald C, Damato BE, et al. Prognostic biopsy of choroidal melanoma: an optimised surgical and laboratory approach. Br J Ophthalmol. 2017;101:1143–6.
doi: 10.1136/bjophthalmol-2017-310361 pubmed: 28596284
Damato B, Angi M, Coupland SE, Heimann H, Groenewald C. Miscellaneous Uveal Biopsy Techniques. In: Damato B, Singh AD, editors. Clinical Ophthalmic Oncology: Uveal Tumors. Berlin, Heidelberg: Springer; 2014. https://doi.org/10.1007/978-3-642-54255-8_4 .
Sen J, Groenewald C, Hiscott PS, Smith PA, Damato BE. Transretinal Choroidal Tumor Biopsy with a 25-Gauge Vitrector. Ophthalmology. 2006;113:1028–31.
doi: 10.1016/j.ophtha.2006.02.048 pubmed: 16751041
Eide N, Walaas L. Fine-needle aspiration biopsy and other biopsies in suspected intraocular malignant disease: a review. Acta Ophthalmol. 2009;87:588–601.
doi: 10.1111/j.1755-3768.2009.01637.x pubmed: 19719804
Seregard S, All-Ericsson C, Hjelmqvist L, Berglin L, Kvanta A. Diagnostic incisional biopsies in clinically indeterminate choroidal tumours. Eye. 2013;27:115–8.
doi: 10.1038/eye.2012.219 pubmed: 23154498
Kvanta A, Seregard S, Kopp ED, All-Ericsson C, Landau I, Berglin L. Choroidal Biopsies for Intraocular Tumors of Indeterminate Origin. Am J Ophthalmol. 2005;140:1002–6.
doi: 10.1016/j.ajo.2005.06.025 pubmed: 16376642
Grixti A, Angi M, Damato BE, Jmor F, Konstantinidis L, Groenewald C, et al. Vitreoretinal Surgery for Complications of Choroidal Tumor Biopsy. Ophthalmology. 2014;121:2482–8.
doi: 10.1016/j.ophtha.2014.06.029 pubmed: 25085629

Auteurs

Vanessa Otti (V)

University College London Medical School, London, UK.
Ocular Oncology Service, Moorfields Eye Hospital, London, UK.

Caroline Thaung (C)

Ocular Oncology Service, Moorfields Eye Hospital, London, UK.

Hardeep Singh Mudhar (HS)

Department of Histopathology, Royal Hallamshire Hospital, Sheffield, UK.

Bertil Damato (B)

Ocular Oncology Service, Moorfields Eye Hospital, London, UK.

Mandeep S Sagoo (MS)

Ocular Oncology Service, Moorfields Eye Hospital, London, UK.
NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, UK.

Hibba Quhill (H)

Ocular Oncology Service, Royal Hallamshire Hospital, Sheffield, UK. hibba.quhill@nhs.net.

Classifications MeSH